Back
The Gorman-Rupp Co. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
72
GRC
The Gorman-Rupp Co.
Last Price:
$49.36
Seasonality Move:
2.21%
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.94
Seasonality Move:
-8.13%
Buy
72
The Gorman-Rupp Co. (GRC)
is a Buy
Is The Gorman-Rupp Co. a Buy, Sell or Hold?
-
The current The Gorman-Rupp Co. [GRC] share price is $50.43. The Score for GRC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
GRC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRC Stock Price Chart
What is The Gorman-Rupp Co.'s stock price today?
-
The The Gorman-Rupp Co. share price today is $50.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRC is experiencing selling pressure, which indicates risk of future bearish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $32.59The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 75.26 | Buy |
| Chaikin Money Flow: | -145603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.2 - 47.86) | Buy |
| Bollinger Bands (100): | (42.34 - 46.74) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.39 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | -433025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.95 | Buy |
| 20-day SMA: | 46.3 | Buy |
| 50-day SMA: | 45.98 | Buy |
| 200-day SMA: | 40.5 | Buy |
| 8-day EMA: | 48.43 | Buy |
| 20-day EMA: | 47.04 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 42.11 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.44 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 17.45 | Buy |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 34.32 | Sell |
| 50-day EMA: | 23.15 | Buy |
| 200-day EMA: | 7.97 | Buy |
The Gorman-Rupp Co. Earnings Growth & GRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.24 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
The Gorman-Rupp Co. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||